Coetzee. Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits.
At the molecular level, K ATP channels are understood to be multisubunit protein complexes. Transmembrane Kir6 poreforming subunits allow K ϩ ions to permeate the channel complex, whereas SUR accessory subunits serve to act as receptors for a variety of pharmacological compounds that promote or inhibit K ATP channel opening (28) . The Kir6.x subunit subfamily consists of two members, Kir6.1 and Kir6.2. Similarly, two SUR subunits exist (SUR1 and SUR2) (28) . Alternative splicing of SUR2 gives rise to at least two functionally relevant isoforms (SUR2A and SUR2B) with distinct pharmacological profiles (28) . Because K ATP channels are hetero-octameric complexes consisting of four Kir6.x and four SURx subunits (30) , in principle a large degree of freedom for subunit assembly is possible. This heterogeneous assembly of K ATP channels may explain, in part, the large diversity of native K ATP channels found in various tissue types (1) . The consensus is that ventricular K ATP channels consist of Kir6.2/ SUR2A heteromultimers and that K NDP channels in vascular smooth muscle consist of Kir6.1 and SUR2B subunits (28) . Gene targeting approaches confirm an important role for these subunits in the respective tissues because Kir6.2(Ϫ/Ϫ) mice lack functional sarcolemmal K ATP channels and both Kir6.1(Ϫ/Ϫ) and SUR2(Ϫ/Ϫ) mice develop coronary abnormalities (2, 17) . However, these results do not explain the presence of Kir6.1 or SUR1 in cardiac myocytes (17, 19, 32) or the observation that anti-SUR1 antisense oligonucleotides inhibit K ATP channels of ventricular myocytes (41) . Thus the molecular composition of K ATP channels and the functional roles of the individual subunits may therefore not be as clearcut as previously thought. Gene targeting experiments demonstrated that (as expected) Kir6.2-deficient mice do not have functional K ATP channels in ventricular myocytes (33) . Although the initial report suggested no apparent cardiac abnormalities, subsequent studies demonstrated that Kir6.2(Ϫ/Ϫ) mice fail to adapt to sympathetic stress. They develop lethal cardiac arrhythmias and sudden death with sympathetic challenge (42). Because Kir6.2 subunits are lost in all tissues (central and peripheral nervous tissue, heart, and other tissues), it is not possible from these experiments to conclude whether these defects originate primarily from the absence of Kir6.2 in the heart or whether other systemic malfunctions may be involved (the sympathetic nervous system, for example). We developed transgenic mouse lines to specifically target K ATP channels in the ventricular myocyte by driving Kir6.x dominant negative subunit expression by the ␣-myosin heavy chain promoter. We show that these mice have many of the hallmarks of the Kir6.2(Ϫ/Ϫ) mice (including intolerance to exercise stress). We conclude that the functional roles of K ATP channels in the intact mouse (particularly under stress conditions) originate at least in part from the role of these channels within the cardiac myocyte.
MATERIALS AND METHODS
For a full description of the methods, please see the online supplement (http://ajpheart.physiology.org/cgi/content/full/00051.2006/DC1).
Production of transgenic constructs. Amino acid residues in the rat Kir6.1 and mouse Kir6.2 subunit pore regions (Gly-Phe-Gly) were mutated to Ala-Ala-Ala by site-directed mutagenesis (QuickChange, Stratagene). The Kir6.1-AAA construct was COOH-terminal tagged with enhanced green fluorescent protein (eGFP) and the Kir6.2-AAA had a FLAG epitope. The constructs were subcloned into the pBS-␣MHC vector (Dr. J. Robbins, University of Cincinnati, Cincinnati, OH).
Generation of transgenic mice. The transgenic cassettes were excised, purified, and microinjected into the pronuclei of fertilized FVB/N zygotes. The injections were performed at the Transgenic/ES cell Core Facility (Skirball Institute, New York University School of Medicine). Surviving embryos were reimplanted into pseudopregnant FVB/N foster mothers. Genotyping was performed by PCR.
RNA extraction and semi-quantitative RT-PCR. RNA was prepared from mouse hearts. After reverse transcription (Promega), PCR was performed using the following primers: Kir6.2: (1065F: 5Ј-TTCAC-CATGTCCTTCCTGTG-3Ј) and (1008R: 5Ј-ACCAATGGTCACCT-GGACCTC-3Ј, product: 173 bp); Kir6.2AAA-FLAG: (1077F and 1272R, product: 350 bp).
Western blotting. Western blotting was performed using crude membrane fractions obtained from mouse heart and brain using previously described procedures (18) . Equal amount of proteins were separated on 12% SDS-PAGE, transferred to polyvinylidene difluoride membranes, and immunoblotted with anti-Kir6.1 NAF-1 (1: 1,500) or anti-Kir6.2 G16 antibody (1: 500, Santa Cruz Biotechnology). The secondary antibodies were horseradish peroxidase conjugated, and detection was by chemiluminescence.
Histology. Hearts were rapidly excised from mice after death with CO 2, rinsed in Dulbecco's PBS, and fixed in 10% formalin. Sections of 5-m thickness were cut from paraffin-embedded tissue and stained with hematoxylin and eosin.
In vivo electrocardiographic and electrophysiological studies. Electrocardiographic and electrophysiological parameters were examined as described previously (10) . Programmed electrical stimulation was performed consisting of a train of eight beats followed by a single extrastimulus for the determination of ventricular effective refractory period and double extrastimuli to test for inducible arrhythmias. Arrhythmias are defined as described previously (10, 37) . To examine the electrophysiological response to ␤-adrenergic stimulation (42), we repeated measurements of electrocardiographic and electrophysiological parameters after administration of dobutamine (100 g/kg ip).
Hemodynamic studies. Mice were anesthetized with Avertin, intubated endotracheally, and mechanically ventilated. A 1.4F Mikro-Tip catheter pressure transducer (Millar, Houston, TX) was placed into the right carotid and advanced retrograde into the left ventricle.
Epifluorescence measurements of epicardial electrical activity. Isolated hearts were perfused in the Langendorff mode and loaded with di-4-ANEPPS (Molecular Probes). High-resolution optical mapping of voltage-dependent fluorescence during normal sinus rhythm and pacing was acquired using a charge-coupled device camera (Dalsa). Conduction velocity was measured during epicardial pacing.
Treadmill exercise test.
A two-track treadmill (Columbus Instruments, Columbus, OH) was used. The exercise-stress protocol consisted of stepwise increases in either incline or velocity at 3-min intervals. A shock grid at the end of the treadmill delivered a minimal painful stimulus to enforce running. Ten days before exercise stress, mice were acclimated daily. Animal protocols were approved by the Institutional Animal Care and Use Committee at the New York University.
Electrophysiological recordings in isolated ventricular myocytes. Whole-cell macroscopic currents were recorded at room temperature. The pipette solution consisted of (in mmol/l) 115 L-aspartate, 10 KCl, 5 EGTA, 5.92 MgCl 2, 5 Na2ATP, and 10 HEPES, pH adjusted to 7.2 with KOH. The bath solution consisted of (in mmol/l) 143 NaCl, 5.4 KCl, 1.8 CaCl 2, 0.5 MgCl2, 0.33 NaH2PO4, 5 glucose, and 5 HEPES, pH adjusted to 7.4 with NaOH. KATP channel currents were evoked by bath application of 100 mol/l dinitrophenol (DNP; Sigma) and were recorded from a holding potential of Ϫ60 mV using a ramp (100 mV/s) pulse protocol from Ϫ120 to ϩ40 mV, repeated at 1 Hz. Action potentials were recorded in current-clamp mode using pipettes filled with (in mmol/l) KCl 120, MgCl 2 1, Na2ATP 5, HEPES 10, EGTA 0.5, and CaCl2 0.01.
Immunofluorescence microscopy. Immunocytochemistry was performed on isolated mouse cardiomyocytes as described (19) . Primary antibodies used were rabbit anti-Kir6.1 (NAF1, 1:200) (19 
RESULTS
Generation of transgenic mice lacking cardiac K ATP channels. We utilized a dominant negative strategy to transgenically target K ATP channels in ventricular myocytes. The pore regions of Kir6.1 or Kir6.2 subunits were mutated by replacing the Gly-Phe-Gly residues to Ala-Ala-Ala, which act to suppress wild-type Kir6 currents in a dominant negative manner (27) . Expression of these subunits was driven by the cardiac-myocyte-specific ␣-myosin heavy chain (␣-MHC) promoter (Fig.  1 ). ␣-MHC-Kir6.1-AAA-eGFP (hereafter referred as Kir6.1-AAA) transgenic mice were produced in a FVB/N background, whereas ␣-MHC-Kir6.2-AAA-FLAG (referred as Kir6.2-AAA) mice were in a C57BL/6 background. Both of these mice expressed the respective transgene specifically in the heart, as verified by RT-PCR and Western blotting (Fig. 1 , B and C). Kir6.2 protein levels were higher in Kir6.2-AAA transgenic mice compared with their control littermates. However, Kir6.2 expression levels were similar in heart membrane fractions of Kir6.1-AAA transgenic mice and their control littermates. Similarly, by Northern blot we determined that native Kir6.1 mRNA expression was not affected in Kir6.2-AAA transgenic mouse hearts compared with their control littermates (data not shown). We produced several lines of each transgenic construct. None of them exhibited adverse morphological or functional phenotypes at an early age. The results shown here are from one line of each transgenic model.
Phenotypic analysis of transgenic mice. The Kir6 poremutant transgenic mice had a birth ratio as expected from Mendelian principles, suggesting that mice developed normally in utero (data not shown). The male-to-female ratio was close to 1:1. Mice developed normally after birth, as evident from weight-gain charts constructed during the first 2 mo after birth (Fig. 2, A and B) . Body length (measured from nose to tip of tail) was also not different between transgenic groups and their control littermate groups (data not shown). At the end of 8 wk, animals were killed and the weights of several tissues were obtained. There was no significant difference between transgenics and control littermates in the weights of the heart, liver, kidney, or brain (data not shown).
Up to about 16 wk of age, survival rate was identical in the transgenic groups and control littermates. Thereafter, both Kir6.x transgenic mice exhibited an increased mortality compared with their control littermates (Fig. 2, C and D) . To avoid the effect of age-related mortality, younger mice (3-4 mo old) were used for the most of studies. Although not studied in detail, there was no evidence of the vasospasm and early death observed in Kir6.1 (Ϫ/Ϫ) mice (17) . Thus there are clearly distinct roles for cardiac K ATP channels and those in the coronary vascular smooth muscle and/or endothelium.
Histologically, there were no obvious differences between the hearts of transgenic and control littermates (Fig. 3) .
Subcellular expression of Kir6.1-AAA-eGFP in cardiac myocytes. The COOH-terminal flag failed to be recognized in tissues from transgenic animals (not shown). This may be due to masking of the epitope or possibly cleavage of the FLAG epitope. The Kir6.1 pore mutant was tagged with eGFP, which remained intact in vivo as demonstrated by a band of ϳ70 kDa 1 and 3, respectively) . The primary antibody used was anti-Kir6.2-G16 (1:500). in SDS-PAGE of heart lysates (Fig. 1D) . The Kir6.1-AAAeGFP subunits were distributed in a sarcomeric pattern (Fig.  4A ), which is a subcellular distribution similar to that obtained for native Kir6.1 subunits (e.g., Fig. 4B1 ; see also Ref. 19 ). The expression pattern observed either by eGFP fluorescence or anti-Kir6.1 staining was not similar to mitochondrial staining (Fig. 4C) .
Ventricular myocytes from transgenic mice lack sarcolemmal K ATP channel currents. Whole-cell patch clamping was performed. There were no differences in the membrane capacitances or reversal potentials of the current-voltage relationships between controls and transgenics (not shown). The current density at Ϫ90 mV was similar between the Kir6.1-AAA transgenics and their control littermates (a small difference was observed for Kir6.2-AAA transgenics), but current density at 0 mV was smaller in myocytes from transgenic mice (Fig. 5) . K ATP channel currents were activated by metabolic inhibition in control myocytes, which were partly reversed by glibenclamide (1 mol/l, data not shown), but DNP (100 mol/l) failed to elicit K ATP channel currents in transgenic mice. For example, in Kir6.1 control littermates, the maximal effect of DNP was within 5.7 Ϯ 1.6 min, whereas no DNP-activated current was observed even after 11 Ϯ 1.1 min of DNP application in Kir6.1-AAA cardiomyocytes (at which time hypercontracture occurred; not shown). Similar data were seen with the Kir6.2-AAA transgenic mice (Fig. 5) . Similarly, pinacidil or bimakalim failed to activate K ATP channels in transgenic myocytes (not shown). Thus both transgenic mice lack sarcolemmal K ATP channels.
Prolonged action potentials in Kir6.x transgenic mice. Action potentials were recorded under current-clamp conditions. There were no differences in the resting membrane potentials (Table 1) . However, the action potential duration was prolonged in both transgenic mice. Isoproterenol (1 mol/l) led to an action potential prolongation (Table 1 ) and some of the transgenic (but not control) myocytes developed early afterdepolarizations (EADs; 2 of 9 cells in the Kir6.1-AAA group and 1 of 9 cells in the Kir6.2-AAA group; Fig. 6 ).
Ventricular function is unchanged in Kir6.x transgenic mice.
We next examined hemodynamic parameters of anesthetized transgenic mice. At baseline, Kir6.1-AAA transgenic mice had a modestly but significantly increased heart rates compared with age-matched controls (Table 2) ; the heart rate was not different between Kir6.2-AAA and their control littermates. Other hemodynamic parameters, including left ventricular systolic pressure, left ventricular end-diastolic pressure, ϩdP/dt (where P is pressure and t is time), ϪdP/dt, and the relaxation constant Tau, were unchanged, suggesting that ventricular function was largely unchanged in the transgenic mice.
Kir6.x transgenic mice have an increased refractory period. In vivo electrophysiological parameters were similar in anesthetized transgenic mice and their control littermates. The basal heart rate was slightly elevated in Kir6.1-AAA transgenic mice (decreased R-R interval, Table 3 ). This was not observed with Kir6.2-AAA transgenic mice. Other electrocardiographic parameters were unchanged. Interestingly, the QRS amplitude was significantly decreased in Kir6.2-AAA (but not Kir6.1-AAA) mice.
The ventricular effective refractory period was determined by using programmed electrical stimulation (10) and was prolonged in both transgenic mice. Overall, the incidence of nonsustained ventricular tachycardia was very low and not different between groups. None of the mice tested exhibited sustained ventricular tachycardia.
We also investigated the response to ␤-adrenoceptor activation. Dobutamine had essentially similar effects in the transgenic animals as observed in their nontransgenic littermates. In this regard, the transgenic animals differ from the Kir6.2(Ϫ/Ϫ) mice, which have a compromised response to isoproterenol (14) .
No conduction abnormalities in Kir6.x transgenic mice. Sinus rhythm activation patterns of activation were similar in transgenics and controls (not shown). Pacing experiments revealed no differences in conduction velocities of either the left or right ventricles (not shown). Kir6.x transgenic mice exhibit a compromised exercise capacity. Kir6.2(Ϫ/Ϫ) mice are known to have a reduced exercise capacity (42). To examine the effect of cardiac-specific loss of K ATP channels, we performed a treadmill test using one of the transgenic models. Kir6.1-AAA transgenic mice (mean age of 18 wk) performed less well on this test, both in terms of the time on the treadmill and the workload performed. The running time on treadmill was 29.6 Ϯ 3.4 min (vs. 41.1 Ϯ 3.8 min for control littermates, P Ͻ 0.05) and the workload performed was 10.4 Ϯ 2.9 J (vs. 19.9 Ϯ 4.3 J in control, P Ͻ 0.05).
DISCUSSION
We generated two transgenic mouse models that specifically lack cardiac myocyte K ATP channels. Young mice did not have an overt phenotype, whereas older mice exhibited increased mortality. Hemodynamics and ECG parameters were relatively normal, but with programmed electrical stimulation the transgenic mice have a prolonged refractory period. Action potentials were prolonged in myocytes from transgenic mice, and early afterpotentials could be provoked with ␤-receptor stimulation. Transgenic mice performed less well in an exercise stress test. Both Kir6.x transgenic mice lack K ATP channels. A clear role for Kir6.2 subunits has been identified in forming cardiac sarcolemmal K ATP channels (28) . However, Kir6.1 subunits are also expressed in ventricular cells (19) (also see Fig. 4 ) and atrial K ATP channels may have a Kir6.1 component (38) , but the functional role of this subunit is far from clear. We found transgenic expression of either Kir6.1 or Kir6.2 dominant negative subunits to abolish sarcolemmal K ATP channels. The mechanism by which this occurred is not entirely clear, especially because Kir6.1 and Kir6.2 subunits may not have an identical subcellular localization (19, 31) . The most reasonable explanation is that these mutant subunits competed with native Kir6.2 subunits for the available SUR2A pool, thus preventing the latter from trafficking normally and forming functional K ATP channels. This explanation is consistent with the recent observations that transgenic overexpression of SUR1 and Kir6.2 constructs also demonstrate marked dominant-negative phenotypes (6, 13) . Regardless of the mechanism, transgenic expression of mutant Kir6.x subunits resulted in hearts lacking K ATP channels, as assessed with patch-clamp methods. Having two independent models of mice lacking K ATP channels with essentially identical features strongly rules against integrational nonspecificity of the transgenes. Sarcolemmal vs. mitochondrial K ATP channels. The transgenic mice lacked sarcolemmal K ATP channels. However, mitochondria also contain K ATP channels (26) . We saw no obvious colocalization of the Kir6.1-AAA subunits (tagged with eGFP), with the mitochondrial-specific dye MitoTracker red (similar experiments could not be performed to localize Kir6.2-AAA subunits because the FLAG epitope was not detected in transgenic myocytes). Thus our data suggest that sarcolemmal, but not mitochondrial, K ATP channels were lost in our transgenic mouse models. However, we cannot rule out the possibility of disruption of the mitochondria K ATP channel activity without further experimentation.
Action potential duration lengthening in transgenic myocytes. Similar to the Kir6.2(Ϫ/Ϫ) mice (33) , the shape of the current-voltage relation was similar (but not identical) in control and transgenic myocytes under voltage-clamp conditions. The current densities at Ϫ90 mV were similar between the transgenic and control groups. However, the current density at 0 mV was smaller in transgenics (Fig. 5) , which is consistent with the longer action potentials in transgenics. One interpretation of these data is that there may be a small but significant activation of K ATP channels at near-physiological pacing rates in the nontransgenic mouse, which is not present in the transgenic mouse. Such an interpretation would be consistent with reports that K ATP channel blockade with glibenclamide increases the rat ventricular action potential duration under nonischemic conditions in some studies (3, 40) and that glibenclamide caused QT prolongation in a clinical trial of patients with type II diabetes (20) . However, a contribution of K ATP channels to the action potential is not always observed (16, 33) , Fig. 5 . Lack of sarcolemmal ATP-sensitive K ϩ (KATP) channels in cardiac myocytes from Kir6.1-AAA and Kir6.2-AAA mice. Whole cell patch clamping was performed using enzymatically isolated ventricular myocytes. Ramp voltage-clamp pulses were applied from a holding potential of Ϫ60 mV. KATP channels were activated by metabolic inhibition (100 mol/l dinitrophenol) until maximum KATP channel activation occurred; usually within a few minutes. If no KATP channel current was activated, perfusion was stopped when cell hypercontracture occurred. The genotypes are indicated in the individual panels. In the bar graphs, A refers to the current densities at Ϫ90 mV in Tyrode's solution, B to the current densities at 0 mV in Tyrode's solution, and C to the current densities at 0 mV in the presence of dinitrophenol (DNP). Data are expressed as means Ϯ SE of 6 -10 experiments from 3-4 animals. and the relative contribution of K ATP channels to the action potential may depend on unidentified factors (such as the cellular condition, pacing rate, stress, etc.). Our data do not directly address the issues of whether K ATP channels are open under basal conditions or the possibility of metabolic compromise of the isolated myocytes. It is also possible that a degree of remodeling may have occurred in some of the other repolarizing membrane currents, such as the alterations in the Ca 2ϩ current, as observed in another transgenic mouse model overexpressing a constituently active K ATP channel subunit (5) .
K ATP channels and arrhythmogenesis. The effective refractory period was prolonged in transgenic mice lacking cardiac K ATP channels. Experimentally, incessant ventricular tachycardia can be partly explained by an increase of functional conduction block and/or decrease of the wavelength of excitation (conduction velocity ϫ refractory period) as actions favoring reentry. A shortened refractory period may therefore be proarrhythmic (29) . Thus, although at first sight a prolonged effective refractory period may be considered antiarrhythmic, many drugs (including those with class III action) are in fact proarrhythmic by prolonging the action potential duration, which in turn increases the effective refractory period. The link between K ATP channel activity and refractoriness has been noted by others. For example, blockade of K ATP channels with glibenclamide increases the effective refractory period in an isolated rabbit heart preparation (40) . Furthermore, the progressive shortening of the effective refractory period characteristic of atrial fibrillation has been argued to be due to activation of the K ATP channels during rapid atrial rates (39) . Conversely, K ATP channel opening by pinacidil or cromakalim has been described to be associated with a reduction in effective refractory periods in experimental models (4, 35) . Taken together, the lengthened effective refractory period and possible dispersion of refractoriness caused by the absence of K ATP channel may be responsible for an increased susceptibility to arrhythmias. Conversely, the argument can be made that K ATP channels, by shortening the action potential and effective refractory period, may have a protective role against the onset of ventricular arrhythmias. We found mechanistic support for possible arrhythmic features of myocytes lacking K ATP channels at the cellular level. First, the action potential was prolonged in myocytes from transgenic mice. Second, EADs appeared after isoproterenol treatment in some transgenic, but not in control littermates, myocytes. A similar observation has been made for Kir6.2(Ϫ/Ϫ) mice, in which catecholamine challenge predisposes the myocardium to Data are group means Ϯ SE; LV, left ventricular; LVEDP, left ventricular end-diastolic pressure; dP/dt, change in pressure over time; Tau, relaxation constant. n ϭ 5 controls and 6 Kir6.1-AAA; n ϭ 5 controls and n ϭ 5 Kir6.2-AAA. *P Ͻ 0.05 compared with matched controls. Fig. 6 . Action potential recordings obtained under current-clamping conditions. The mouse genotype is illustrated above each panel. Each panel contains 2 action potential traces (superimposed in the top 2 panels): 1 recorded during control conditions and another recorded within a few minutes after addition of isoproterenol (Iso). The pacing rate was 2 Hz. Note the prolonged action potential duration in the transgenic myocytes, which was further prolonged by isoproterenol.
afterpotentials (14) . Furthermore, K ATP channel blockade with glibenclamide also predisposes to afterpotentials (25) . Prolonged action potentials increase the susceptibility of EAD occurrence, which is a possible explanation for this arrhythmia in our transgenic mouse model. However, there may also be a role for a poorly understood link between K ATP channels and intracellular Ca 2ϩ cycling, which has been most clearly demonstrated in transgenic mice expressing cardiac ATP-insensitive mutant Kir6.2 subunits (5). This collection of in vivo and in vitro data underscores the role that K ATP channels may have in repolarization (particularly at high pacing rates and with catecholamine challenge) and the role that K ATP channels may have in protecting the heart against potentially lethal arrhythmias. A caveat to note is that we failed to observe any serious arrhythmias in the in vivo electrophysiology study with the ␤-agonist dobutamine.
A role of cardiac K ATP channels in cardiovascular function under conditions of stress. Evidence is compiling to show that K ATP channels contribute to excitability under conditions of stress. In addition to the numerous studies published to demonstrate a role for K ATP channels during hypoxia and ischemic events (8, 34) , as well as participation in protection of the heart during ischemic preconditioning (7, 23) , recent studies additionally point to a role for K ATP channels in more "physiological" stress conditions, such as exercise and rapid heart rates. For example, in an exercise-stress test, Kir6.2 knockout mice perform at a significantly reduced level compared with ageand gender-matched nontransgenic controls (42). When subjected to chronic exercise, these mice also exhibited less augmentation in exercise capacity and lacked metabolic improvement in body fat composition and glycemic handling (11) . The fact that our transgenic mice are also intolerant of stress further underscores the important role of K ATP channels in protection against a stress response.
Cardiac intrinsic vs. extrinsic cardiovascular effects of K ATP channel deletion. Although they are powerful tools, geneknockout approaches can overemphasize certain important aspects of gene function and may overlook more subtle effects of protein function. Furthermore, gene knockout results in lack of the target protein in all somatic cells and it may be difficult to dissociate the role of a protein in a particular organ or biological system from other somatic effects. The creation of Kir6.2(Ϫ/Ϫ) and Sur2(Ϫ/Ϫ) mice has been invaluable in understanding the role of K ATP channels (28) . However, interpretation of phenotypes can be complicated by loss of K ATP channels in multiple tissues. For example, the deficit in a stress response of Kir6.2(Ϫ/Ϫ) mice could result from absence of K ATP channels in the nervous system (centrally or peripherally), in skeletal muscle, or in the heart itself. Furthermore, even though isolated hearts from Kir6.2(Ϫ/Ϫ) mice were used in some studies to delineate the role of K ATP channels in ischemia-reperfusion and preconditioning (9, 34) , the contribution of K ATP channels to norepinephrine release from sympathetic nerve endings (24) and the associated effects of neurotransmitters on ischemia-related events (12) cannot be excluded. Using a transgenic approach to ablate K ATP channels specifically in cardiac muscle, we were able to recapitulate the impaired stress response, demonstrating that this response is intrinsic (at least in part) to the myocardium. Our transgenic mice also shared other features with Kir6.2(Ϫ/Ϫ) mice, including a predisposition of the myocardium to EADs (and thus a high risk for induction of triggered activity and ventricular arrhythmias), suggesting that K ATP channel-mediated protection against arrhythmias is also a myocardial-intrinsic feature. The prolonged effective refractory period in our transgenic mice can be interpreted along the same lines (because invasive electrophysiology studies have not been performed in Kir6.2 knockout mice, these data cannot be directly compared with that mouse model).
In summary, disruption of K ATP channels specifically in the myocardium leads to some of the same phenotypes observed in Kir6.2 knockout mice. These phenotypes, which include increased mortality, electrophysiological alterations, and lack of adaptation to a stress response, suggest that these features are intrinsic to the myocardium and that cardiac K ATP channels have an important role in protecting the heart from lethal arrhythmias and adaptation to stress situations.
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